Skip to main content

Table 2 Pretreatment characteristics of patients according to treatment series and HIV status

From: Serial counts of Mycobacterium tuberculosis in sputum as surrogate markers of the sterilising activity of rifampicin and pyrazinamide in treating pulmonary tuberculosis

 

SHT

SHRZ

HIV-

HIV+

No. of patients

67

55

85

37

Mean age

30.0

30.3

29.5

31.5

Per cent males

59.7

60.0

61.2

56.8

Mean lung zone (Max. 6)

4.37

4.15

4.48

3.78*

Mean cavitation (Max. 6)

1.31

1.29

1.65

0.51†

Mean initial log cfu count

6.84

6.72

6.95

6.34

  1. * p = 0.007 †p = 0.000001 p = 0.007
Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us